Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Kermani

Showing results (101-110 of 119) with videos related to

Pageof 12
Sort By:
The Journal of Rheumatology|March 17, 2019
Update on Outcome Measure Development in Large-vessel Vasculitis: Report from OMERACT 2018Sibel Z Aydin, Joanna C Robson, Antoine G Sreih, et al.
Rheumatology (Oxford, England)|November 8, 2017
Evaluation of damage in giant cell arteritisTanaz A Kermani, Antoine G Sreih, David Cuthbertson, et al.
The Journal of Rheumatology|April 3, 2016
The Birmingham Vasculitis Activity Score as a Measure of Disease Activity in Patients with Giant Cell ArteritisTanaz A Kermani, David Cuthbertson, Simon Carette, et al.
Seminars in Arthritis and Rheumatism|June 9, 2018
Arterial lesions in giant cell arteritis: A longitudinal studyTanaz A Kermani, Sehriban Diab, Antoine G Sreih, et al.
Mayo Clinic Proceedings|September 7, 2021
Clinical Heterogeneity of the VEXAS Syndrome: A Case SeriesMatthew J Koster, Taxiarchis Kourelis, Kaaren K Reichard, et al.
Interactive Journal of Medical Research|May 25, 2022
Self-Reported Data and Physician-Reported Data in Patients With Eosinophilic Granulomatosis With Polyangiitis: Comparative AnalysisIrena Doubelt, Jason M Springer, Tanaz A Kermani, et al.
The Journal of Rheumatology|September 3, 2017
OMERACT Endorsement of Patient-reported Outcome Instruments in Antineutrophil Cytoplasmic Antibody-associated VasculitisJoanna C Robson, Gunnar Tomasson, Nataliya Milman, et al.
Blood|May 24, 2022
Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter studyMaël Heiblig, Marcela A Ferrada, Matthew J Koster, et al.
The Journal of Rheumatology|July 3, 2018
Assessing Vasculitis in Giant Cell Arteritis by Ultrasound: Results of OMERACT Patient-based Reliability ExercisesValentin S Schäfer, Stavros Chrysidis, Christian Dejaco, et al.
RMD Open|June 5, 2018
Definitions and reliability assessment of elementary ultrasound lesions in giant cell arteritis: a study from the OMERACT Large Vessel Vasculitis Ultrasound Working GroupStavros Chrysidis, Christina Duftner, Christian Dejaco, et al.
Pageof 12

Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
The Journal of Rheumatology|March 17, 2019
Update on Outcome Measure Development in Large-vessel Vasculitis: Report from OMERACT 2018Sibel Z Aydin, Joanna C Robson, Antoine G Sreih, et al.
Rheumatology (Oxford, England)|November 8, 2017
Evaluation of damage in giant cell arteritisTanaz A Kermani, Antoine G Sreih, David Cuthbertson, et al.
The Journal of Rheumatology|April 3, 2016
The Birmingham Vasculitis Activity Score as a Measure of Disease Activity in Patients with Giant Cell ArteritisTanaz A Kermani, David Cuthbertson, Simon Carette, et al.
Seminars in Arthritis and Rheumatism|June 9, 2018
Arterial lesions in giant cell arteritis: A longitudinal studyTanaz A Kermani, Sehriban Diab, Antoine G Sreih, et al.
Mayo Clinic Proceedings|September 7, 2021
Clinical Heterogeneity of the VEXAS Syndrome: A Case SeriesMatthew J Koster, Taxiarchis Kourelis, Kaaren K Reichard, et al.
Interactive Journal of Medical Research|May 25, 2022
Self-Reported Data and Physician-Reported Data in Patients With Eosinophilic Granulomatosis With Polyangiitis: Comparative AnalysisIrena Doubelt, Jason M Springer, Tanaz A Kermani, et al.
The Journal of Rheumatology|September 3, 2017
OMERACT Endorsement of Patient-reported Outcome Instruments in Antineutrophil Cytoplasmic Antibody-associated VasculitisJoanna C Robson, Gunnar Tomasson, Nataliya Milman, et al.
Blood|May 24, 2022
Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter studyMaël Heiblig, Marcela A Ferrada, Matthew J Koster, et al.
The Journal of Rheumatology|July 3, 2018
Assessing Vasculitis in Giant Cell Arteritis by Ultrasound: Results of OMERACT Patient-based Reliability ExercisesValentin S Schäfer, Stavros Chrysidis, Christian Dejaco, et al.
RMD Open|June 5, 2018
Definitions and reliability assessment of elementary ultrasound lesions in giant cell arteritis: a study from the OMERACT Large Vessel Vasculitis Ultrasound Working GroupStavros Chrysidis, Christina Duftner, Christian Dejaco, et al.
Pageof 12